Anjac Health & Beauty strengthens its position in North America and its pharmaceutical activities

Anjac Health & Beauty (Anjac) has announced the acquisition of Pillar5 Pharma (Pillar5), a leading CDMO specialized in the production of sterile ophthalmic solutions and niche solid forms (tablets, capsules, etc.). This operation confirms Anjac's international expansion and extends its healthcare offering with a new ophthalmic range to serve local and international brands and laboratories. This is Anjac's second major operation in 2022, following the merger with Apollo Healthcare last January.

Pillar5, CDMO a key player in the sterile ophthalmology market in North America.

A Canadian company, Pillar5 is one of North America's leading CDMOs for the production of sterile ophthalmic solutions and solid forms (tablets, capsules, etc.) Pillar5 is a pioneer and the only CDMO to offer innovative ophthalmic solutions on the North American market, namely preservative-free sterile multidoses.

An independent company since 2009, Pillar5, based in Arnprior, Ontario, offers a complete range of services, from product formulation and manufacture to packaging customization and technical services. With a diversified and loyal customer portfolio, Pillar5 supports major pharmaceutical companies as well as ophthalmic care specialists.

The company has 150 employees and sales of $CAD 50 million.

A unique entrepreneurial dynamism

With Pillar5, the Anjac group signs its 9ᵉ acquisition in five years, and sees its overall sales reach almost 650 million euros following this operation, doubling in the space of three years. Each new acquisition represents an opportunity for the Anjac Group to extend its range of services in specific fields, while leveraging their complementarities. The Anjac Group now comprises 14 expert companies, with 22 R&D and manufacturing sites.

"We are delighted with this strategic acquisition, which will enable us to expand into a key new segment, the ophthalmic market, and more specifically into the high value-added innovation of preservative-free, multi-dose sterile ophthalmic solutions.explains Aurélien Chaufour, President of the Anjac Group.

"We are delighted to be joining a family-owned industrial group that will support us in our ambitious expansion plans. We have already identified synergies, notably with international customers who can be supported by Pillar5 and other companies in the Anjac group".says Dwight Gorham, President and CEO of Pillar5.

Sponsored content

site-industries-cosmetiques Two cylindrical glass bottles with pump dispensers, one filled with orange gel beads and the other with blue gel beads, stand upright on a white background - perfect for storing CSR products in style.

D.I.V.A.S., Technature's Technology Pushing the Boundaries of Formulation

Technature adds a new galenic formulation to its expertise.
site-industries-cosmetiques A woman with radiant, structured skin smiles and looks to the side. The superimposed text reads: "in-cosmetics Award finalist CRODA Beauty". Abstract pink shapes are in the background.

Malvallin, The New Era of Skin Longevity for Structured and Expressive Skin

If you could reinforce your skin before the first signs even show? Discover our next-generation active embracing a proactive approach.
site-industries-cosmetiques Two elegant red mascara tubes bearing the inscription "MY MUST" are presented on a dark red and black background. One tube is upright, while the other lies horizontally. The Lumson logo appears on the left.

MOON: mascara in glass by Lumson and Ponzini

Lumson launches MOON, its first glass mascara in partnership with Ponzini, resulting in the made in Italy collection: ALL EYES ON ME.

Related articles

Our last issue

Listen to us!

Newsletter